In the fourth quarter, Jiangsu Phoenix Property Investment (600716.SH) recorded a total sales amount of 266 million yuan for commercial residential properties, a 10.76% decrease compared to the same period last year.
Phoenix Corporation (600716.SH) announcement, October-December 2024: The company's sales area of commercial residential properties...
Announcement of Jiangsu Phoenix Property Investment (600716.SH), October to December 2024: The company's contracted sales area of commodity housing is 11,449.92 square meters, an increase of 32.72% compared to the same period last year; the contracted sales amount is 266 million yuan, a decrease of 10.76% compared to the same period last year. This year, the main signing area is 6,945.25 square meters in Zhenjiang Heyi Residence, with an amount of 77.078 million yuan; while in the same period last year, the main signing areas were 4,303.21 square meters in Nanjing Zijin and Xufu Shoukai, with an amount of 233.7987 million yuan. (This sales data is unaudited and provided by the marketing department. The final data is subject to annual accounting audit.)
Related Articles

How is the layout of the US consumer sector? UBS Group AG's top picks include PepsiCo, Inc. (PEP.US) and Peloton (PTON.US).

HK Stock Market Move | SENSETIME-W (00020) surges more than 5%, Goldman Sachs raises expectations for company's ToC business expansion, generative AI drives innovation in X business development.

HK Stock Market Move | NIO-SW(09866) rises by over 5%, new ES8 set to launch soon, institutions optimistic about the company's prospects for reducing costs and increasing efficiency.
How is the layout of the US consumer sector? UBS Group AG's top picks include PepsiCo, Inc. (PEP.US) and Peloton (PTON.US).

HK Stock Market Move | SENSETIME-W (00020) surges more than 5%, Goldman Sachs raises expectations for company's ToC business expansion, generative AI drives innovation in X business development.

HK Stock Market Move | NIO-SW(09866) rises by over 5%, new ES8 set to launch soon, institutions optimistic about the company's prospects for reducing costs and increasing efficiency.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025